Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity

Nature Medicine

Volumn 18, Issue 7, 2012, Pages 1060-1068

  Zeissig, Sebastian ^a,b   Murata, Kazumoto ^c   Sweet, Lindsay ^a   Publicover, Jean ^d   Hu, Zongyi ^c   Kaser, Arthur ^a,f   Bosse, Esther ^b   Iqbal, Jahangir ^e   Hussain, M Mahmood ^e   Balschun, Katharina ^b   Röcken, Christoph ^b   Arlt, Alexander ^b   Günther, Rainer ^b   Hampe, Jochen ^b   Schreiber, Stefan ^b   Baron, Jody L ^d   Branch Moody, D ^a   Jake Liang, T ^c   Blumberg, Richard S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; LIPID; PHOSPHOLIPASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL PROTECTION; DISORDERS OF LIPID METABOLISM; ENDOPLASMIC RETICULUM; ENZYME RELEASE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; LIVER CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS EXPRESSION; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; ANIMALS; ANTIGENS, CD1D; BIOLOGICAL MARKERS; CARRIER PROTEINS; COCULTURE TECHNIQUES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; IMMUNITY; INTERFERON-GAMMA; LIPID METABOLISM; LYMPHOCYTE ACTIVATION; LYSOPHOSPHOLIPIDS; LYSOSOMES; MICE; NATURAL KILLER T-CELLS; PHOSPHOLIPASES A2, SECRETORY;

HEPATITIS B VIRUS; MUS;

EID: 84863707404     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2811     Document Type: Article

References (55)

1. Thimme, R. et al. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77, 68-76 (2003). (Pubitemid 36004947)
2. Yeo, W. et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J. Clin. Oncol. 27, 605-611 (2009).
3. Esteve, M. et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 53, 1363-1365 (2004). (Pubitemid 39120128)
4. Calabrese, L.H., Zein, N.N. & Vassilopoulos, D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann. Rheum. Dis. 65, 983-989 (2006). (Pubitemid 44133258)
5. Thio, C.L. et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360, 1921-1926 (2002). (Pubitemid 35472132)
6. Guidotti, L.G. & Chisari, F.V. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1, 23-61 (2006).
7. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007). (Pubitemid 46697911)
8. Tupin, E., Kinjo, Y. & Kronenberg, M. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5, 405-417 (2007). (Pubitemid 46780078)
9. Wieland, S., Thimme, R., Purcell, R.H. & Chisari, F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 101, 6669-6674 (2004). (Pubitemid 38586032)
10. Fisicaro, P. et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58, 974-982 (2009).
11. Webster, G.J. et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117-1124 (2000).
12. Guy, C.S., Mulrooney-Cousins, P.M., Churchill, N.D. & Michalak, T.I. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 82, 8579-8591 (2008).
13. Kakimi, K., Guidotti, L.G., Koezuka, Y. & Chisari, F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921-930 (2000).
14. Isogawa, M., Kakimi, K., Kamamoto, H., Protzer, U. & Chisari, F.V. Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. Virology 333, 293-300 (2005). (Pubitemid 40250113)
15. Sprinzl, M.F., Oberwinkler, H., Schaller, H. & Protzer, U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J. Virol. 75, 5108-5118 (2001). (Pubitemid 32448533)
16. von Freyend, M.J. et al. Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B. J. Viral Hepat. 18, 216-226 (2011).
17. Guidotti, L.G. et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825-829 (1999). (Pubitemid 29291352)
18. Publicover, J. et al. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J. Clin. Invest. 121, 1154-1162 (2011).
19. Baron, J.L. et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583-594 (2002). (Pubitemid 34442582)
20. Vilarinho, S., Ogasawara, K., Nishimura, S., Lanier, L.L. & Baron, J.L. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc. Natl. Acad. Sci. USA 104, 18187-18192 (2007). (Pubitemid 350210842)
21. Brozovic, S. et al. CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 10, 535-539 (2004). (Pubitemid 38667914)
22. Dougan, S.K., Rava, P., Hussain, M.M. & Blumberg, R.S. MTP regulated by an alternate promoter is essential for NKT cell development. J. Exp. Med. 204, 533-545 (2007). (Pubitemid 46457077)
23. Dougan, S.K. et al. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 202, 529-539 (2005). (Pubitemid 41186951)
24. Kaser, A. et al. Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules. Eur. J. Immunol. 38, 2351-2359 (2008).
25. Zeissig, S. et al. Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J. Clin. Invest. 120, 2889-2899 (2010).
26. Khatun, I. et al. Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice. Hepatology 55, 1356-1368 (2012).
27. Ganem, D. & Prince, A.M. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350, 1118-1129 (2004). (Pubitemid 38298992)
28. Patient, R., Hourioux, C. & Roingeard, P. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell. Microbiol. 11, 1561-1570 (2009).
29. Satoh, O., Umeda, M., Imai, H., Tunoo, H. & Inoue, K. Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines. J. Lipid Res. 31, 1293-1300 (1990). (Pubitemid 20224727)
30. Arrenberg, P., Halder, R., Dai, Y., Maricic, I. & Kumar, V. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid. Proc. Natl. Acad. Sci. USA 107, 10984-10989 (2010).
31. Gumperz, J.E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221 (2000). (Pubitemid 30398635)
32. Cox, D. et al. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 4, e5325 (2009).
33. Fox, L.M. et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 7, e1000228 (2009).
34. Ni, Z., Okeley, N.M., Smart, B.P. & Gelb, M.H. Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells. J. Biol. Chem. 281, 16245-16255 (2006).
35. Ito, M. et al. Distribution of type V secretory phospholipase A2 expression in human hepatocytes damaged by liver disease. J. Gastroenterol. Hepatol. 19, 1140-1149 (2004). (Pubitemid 39371256)
36. Masuda, S., Murakami, M., Ishikawa, Y., Ishii, T. & Kudo, I. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim. Biophys. Acta 1736, 200-210 (2005). (Pubitemid 41423704)
37. Kuwata, H., Yamamoto, S., Takekura, A., Murakami, M. & Kudo, I. Group IIA secretory phospholipase A2 is a unique 12/15-lipoxygenase-regulated gene in cytokine-stimulated rat fibroblastic 3Y1 cells. Biochim. Biophys. Acta 1686, 15-23 (2004). (Pubitemid 39446874)
38. Tischfield, J.A. et al. Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics 32, 328-333 (1996). (Pubitemid 26094335)
39. Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237 (2003). (Pubitemid 37540692)
40. Brigl, M. et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208, 1163-1177 (2011).
41. Nagarajan, N.A. & Kronenberg, M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178, 2706-2713 (2007). (Pubitemid 46335652)
42. Fujii, S., Liu, K., Smith, C., Bonito, A.J. & Steinman, R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607-1618 (2004). (Pubitemid 38821994)
43. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R.M. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198, 267-279 (2003). (Pubitemid 36987852)
44. Ishak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696-699 (1995).
45. Smiley, S.T., Kaplan, M.H. & Grusby, M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977-979 (1997). (Pubitemid 27087713)
46. Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626 (1997). (Pubitemid 27516281)
47. Van Kaer, L., Ashton-Rickardt, P.G., Ploegh, H.L. & Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71, 1205-1214 (1992). (Pubitemid 23016554)
48. Postic, C. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305-315 (1999). (Pubitemid 29035064)
49. Raabe, M. et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103, 1287-1298 (1999). (Pubitemid 29218299)
50. Mohrs, M., Shinkai, K., Mohrs, K. & Locksley, R.M. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15, 303-311 (2001). (Pubitemid 32816878)
51. Stetson, D.B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069-1076 (2003). (Pubitemid 37248622)
52. Chisari, F.V. et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA 84, 6909-6913 (1987). (Pubitemid 18025500)
53. Scapa, E.F. et al. Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J. 22, 2579-2590 (2008). (Pubitemid 351948675)
54. Ernster, L., Siekevitz, P. & Palade, G.E. Enzyme-structure relationships in the endoplasmic reticulum of rat liver: a morphological and biochemical study. J. Cell Biol. 15, 541-562 (1962).
55. Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509 (1957).